← Back to Search

SAFETY-A + CLASP for Youth Suicide Prevention (YPIC-SP Trial)

Phase 2
Recruiting
Led By David Goldston, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 15-24
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 12 months of follow-up
Awards & highlights

YPIC-SP Trial Summary

This trialwill compare 2 treatments for suicidal youth in the ED. Outcomes monitored at 3, 6 & 12 months.

Who is the study for?
This trial is for young people aged 15-24 who have recently experienced suicidal thoughts or behaviors. They must be able to give informed consent and engage in the study, which means they can't have conditions like active psychosis or drug dependence that would interfere. Participants and their parents must speak English fluently, with parents also having the option of Spanish.Check my eligibility
What is being tested?
The trial compares two approaches for emergency care: SAFETY-A within usual ED Care versus a combination of SAFETY-A and CLASP Therapeutic Follow-Up Contacts. The effectiveness will be monitored over time with follow-up assessments at 3, 6, and 12 months after initial treatment.See study design
What are the potential side effects?
While specific side effects are not detailed here, interventions involving mental health may include emotional distress or discomfort during therapy sessions. Any physical side effects from potential medications used in usual ED care could vary widely.

YPIC-SP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 15 and 24 years old.

YPIC-SP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 12 months of follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and through 12 months of follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mental Health Treatment Initiation: Primary Service Use Outcome
Suicide
Secondary outcome measures
Self-Harm: Secondary Clinical Outcome
Treatment engagement: Secondary Service Use Outcome
Other outcome measures
Ordinal suicidality scale: Clinical
Quality of life and functioning: Clinical

YPIC-SP Trial Design

2Treatment groups
Active Control
Group I: CombinedActive Control1 Intervention
The combined treatment arm includes both 1) SAFETY-A integrated within usual ED Care, and 2) therapeutic follow-up contacts using the Coping Long Term with Active Suicidality Program (CLASP) model.
Group II: SAFETY-Acute within Usual ED CareActive Control1 Intervention
The SAFETY-Acute (A) approach to safety planning and stabilization will be integrated within usual ED Care. SAFETY-A was formerly called the Family Intervention for Suicide Prevention, FISP.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,530 Previous Clinical Trials
10,276,686 Total Patients Enrolled
Duke UniversityOTHER
2,363 Previous Clinical Trials
3,418,993 Total Patients Enrolled
Brown UniversityOTHER
456 Previous Clinical Trials
556,838 Total Patients Enrolled

Media Library

Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts Clinical Trial Eligibility Overview. Trial Name: NCT05304065 — Phase 2
Suicide and Self-Harm Research Study Groups: Combined, SAFETY-Acute within Usual ED Care
Suicide and Self-Harm Clinical Trial 2023: Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts Highlights & Side Effects. Trial Name: NCT05304065 — Phase 2
Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts 2023 Treatment Timeline for Medical Study. Trial Name: NCT05304065 — Phase 2
Suicide and Self-Harm Patient Testimony for trial: Trial Name: NCT05304065 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many medical centers are administering this experiment?

"This clinical trial is available in 5 different venues, such as Duke University located in Durham, Olive View UCLA Education and Research Center situated in Sylmar, the University of Utah based out of Salt Lake City, plus two other locations."

Answered by AI

Is the recruitment process for this experiment currently ongoing?

"As per the clinicaltrials.gov record, this medical trial is currently searching for participants. The initial post was published on October 17th 2022 and underwent an update on November 1st of that same year."

Answered by AI

What is the total number of participants receiving treatment in this research?

"This clinical trial requires 1516 qualified participants to complete the study, with possible recruitment sites located at Duke University in Durham, North carolina and Olive View UCLA Education and Research Center in Sylmar, Utah."

Answered by AI

Am I eligible to join this experiment?

"To be eligible for the study, individuals must have attempted suicide and fall between the ages of 15 to 24. Approximately 1,516 participants are needed to complete this trial."

Answered by AI

Are participants of advanced age eligible for this experimental procedure?

"The parameters of acceptance for this clinical trial dictate that participants must be between 15 and 24 years old."

Answered by AI

Has the FDA granted authorization to Combined?

"We at Power have assigned Combined a safety rating of 2, as the data collected thus far indicates an acceptable level of security yet no proof of efficacy."

Answered by AI

Who else is applying?

What state do they live in?
Rhode Island
How old are they?
18 - 65
What site did they apply to?
Brown University
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I actively meditate after years of struggling with depression and suicidal ideation. I am currently trying an antidepressant and seeking to further research in this area.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

How long does screening visits take? When will i hear from you? What are the variables being tested?
PatientReceived 2+ prior treatments

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. Brown University: < 24 hours
Average response time
  • < 1 Day
Recent research and studies
clinicaltrials.govStudy
Youth Partners in Care for Suicide Prevention
Joan Asarnow 2022. "Youth Partners in Care for Suicide Prevention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05304065.
~970 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top